- Report
- May 2023
- 80 Pages
Vietnam
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
United Kingdom
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
Russia
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
Poland
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
China
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
Brazil
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2023
- 80 Pages
Argentina
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2022
- 40 Pages
Argentina
From €1481EUR$1,500USD£1,233GBP
- Report
- May 2022
- 80 Pages
Africa
From €1975EUR$2,000USD£1,643GBP
- Report
- November 2021
- 80 Pages
Africa
From €1975EUR$2,000USD£1,643GBP
- Report
- November 2021
- 40 Pages
Brazil
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
China
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
France
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
Germany
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
Ireland
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
Japan
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
Russia
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
South Korea
From €1481EUR$1,500USD£1,233GBP
- Report
- November 2021
- 40 Pages
United States
From €1481EUR$1,500USD£1,233GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more